3/24
02:03 pm
jazz
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education [Yahoo! Finance]
Low
Report
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education [Yahoo! Finance]
3/24
01:49 pm
jazz
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
Low
Report
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
3/20
08:02 am
jazz
Top 2026 Long Idea Competition: The Winners [Seeking Alpha]
Low
Report
Top 2026 Long Idea Competition: The Winners [Seeking Alpha]
3/19
02:24 pm
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Piper Sandler from $219.00 to $232.00. They now have an "overweight" rating on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Piper Sandler from $219.00 to $232.00. They now have an "overweight" rating on the stock.
3/19
08:01 am
jazz
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 [Yahoo! Finance]
3/19
06:35 am
jazz
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting [Yahoo! Finance]
Low
Report
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting [Yahoo! Finance]
3/18
07:54 am
jazz
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 [Yahoo! Finance]
3/18
07:44 am
jazz
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Low
Report
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
3/12
12:16 pm
jazz
Jazz Pharmaceuticals plc (JAZZ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Jazz Pharmaceuticals plc (JAZZ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/9
05:01 pm
jazz
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
3/9
07:35 am
jazz
S&P 500 Futures Fall in Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead [Barron's]
Low
Report
S&P 500 Futures Fall in Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead [Barron's]
3/8
07:44 am
jazz
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After Recent Share Price Strength [Yahoo! Finance]
Low
Report
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After Recent Share Price Strength [Yahoo! Finance]
3/5
03:26 am
jazz
Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate [Yahoo! Finance]
3/4
01:05 pm
jazz
Day One Biopharmaceuticals gains amid takeover speculation [Seeking Alpha]
Low
Report
Day One Biopharmaceuticals gains amid takeover speculation [Seeking Alpha]
3/2
11:02 am
jazz
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]
Low
Report
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]
3/1
04:40 am
jazz
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now? [Yahoo! Finance]
Low
Report
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now? [Yahoo! Finance]
2/28
07:02 pm
jazz
Jazz Pharmaceuticals' Record Revenue And Cancer Data Raise Durability Question [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals' Record Revenue And Cancer Data Raise Durability Question [Yahoo! Finance]
2/28
06:33 am
jazz
Why Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Sales But Full-Year Loss [Yahoo! Finance]
Low
Report
Why Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Sales But Full-Year Loss [Yahoo! Finance]
2/27
07:22 pm
jazz
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? [Yahoo! Finance]
2/27
09:16 am
jazz
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress [Yahoo! Finance]
2/27
08:44 am
jazz
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
2/26
03:27 am
jazz
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]
Medium
Report
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]
2/26
02:42 am
jazz
Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
04:57 pm
jazz
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]
Medium
Report
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]
2/25
10:58 am
jazz
Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.